Presentation Information

[3P-053]sPLA2-XIIA is a novel drug target for Th17-driven immune diseases

Chika Mochizuki1, Yoshitaka Taketomi1, Junken Aoki2, Kuniyuki Kano2, Yusuke Endo3, Makoto Murakami1,4 (1.CDBIM, Grad. Sch. of Med., UTokyo, 2.Lab. of Health Chem., Grad. Sch. of Pharm. Sci., UTokyo, 3.Lab. Med. Omics Res., Kazusa DNA Res. Inst., 4.AMED-CREST)
キーテクノロジー:リピドミクス

Keywords:

脂質,ホスホリパーゼA2,リゾリン脂質,細胞外小胞,Th17細胞

Password required to view


Comment

To browse or post comments, you must log in.Log in